Astrana Health Stock Price To Sales
Astrana Health fundamentals help investors to digest information that contributes to Astrana Health's financial success or failures. It also enables traders to predict the movement of Astrana Stock. The fundamental analysis module provides a way to measure Astrana Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Astrana Health stock.
Astrana |
Astrana Health Company Price To Sales Analysis
Astrana Health's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Astrana Health Price To Sales | 1.40 X |
Most of Astrana Health's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Astrana Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, Astrana Health has a Price To Sales of 1.3972 times. This is 93.47% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The price to sales for all United States stocks is 87.77% higher than that of the company.
Astrana Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Astrana Health's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Astrana Health could also be used in its relative valuation, which is a method of valuing Astrana Health by comparing valuation metrics of similar companies.Astrana Health is currently under evaluation in price to sales category among its peers.
Astrana Fundamentals
| Return On Equity | 0.0976 | |||
| Return On Asset | 0.0626 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 1.81 B | |||
| Shares Outstanding | 45.45 M | |||
| Shares Owned By Insiders | 25.77 % | |||
| Shares Owned By Institutions | 46.99 % | |||
| Number Of Shares Shorted | 2.75 M | |||
| Price To Earning | 28.18 X | |||
| Price To Book | 3.12 X | |||
| Price To Sales | 1.40 X | |||
| Revenue | 1.33 B | |||
| Gross Profit | 199.48 M | |||
| EBITDA | 117.97 M | |||
| Net Income | 48.51 M | |||
| Cash And Equivalents | 273.71 M | |||
| Cash Per Share | 6.04 X | |||
| Total Debt | 229.36 M | |||
| Debt To Equity | 0.42 % | |||
| Current Ratio | 2.49 X | |||
| Book Value Per Share | 12.74 X | |||
| Cash Flow From Operations | 133.87 M | |||
| Short Ratio | 17.16 X | |||
| Earnings Per Share | 1.04 X | |||
| Target Price | 46.56 | |||
| Number Of Employees | 1.36 K | |||
| Beta | 1.04 | |||
| Market Capitalization | 1.86 B | |||
| Total Asset | 966.21 M | |||
| Retained Earnings | 192.68 M | |||
| Working Capital | 287.81 M | |||
| Current Asset | 13.56 M | |||
| Current Liabilities | 7.43 M | |||
| Z Score | 7.27 | |||
| Net Asset | 966.21 M |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Astrana Stock
If you are still planning to invest in Astrana Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Astrana Health's history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |